Sort
40,608 grants matching “prostate cancer”
AR Transgene Model of Prostate Intraepithelial Neoplasia
$394,720Beth Israel Deaconess Medical Center · R01 · FY2003 · DK
Regulation of P-Body Formation and mRNA Decapping in Cancer: Control by AKT and Pim Kinase Phosphorylation of EDC3
$394,690Koichi Okumura · University Of Arizona · R21 · FY2020 · CA
Redefining Normal: personalized CA125 cutpoints for ovarian cancer screening
$394,683Kathryn L Terry · Brigham And Women'S Hospital · R01 · FY2017 · CA
Targeting eIF4A1-dependent HK2 translation axis for prevention of castration-resistant prostate cancer
$394,636Yibin Deng · University Of Minnesota · R01 · FY2020 · CA
Targeting eIF4A1-dependent HK2 translation axis for prevention of castration-resistant prostate cancer
$394,636Yibin Deng · University Of Minnesota · R01 · FY2021 · CA
Assessing the Value of Aggressive Treatment of Low-Risk Prostate Cancer
$394,620Jean M Mitchell · Georgetown University · R01 · FY2017 · HS
MTOPS Prostate Samples Analysis Consortium
$394,566University Of Texas Sw Med Ctr/Dallas · U01 · FY2004 · DK
MTOPS Prostate Samples Analysis Consortium
$394,566University Of Texas Sw Med Ctr/Dallas · U01 · FY2003 · DK
MTOPS Prostate Samples Analysis Consortium
$394,566University Of Texas Sw Med Ctr/Dallas · U01 · FY2002 · DK
Clinical Genomic Study
$394,551Kenneth J. Pienta · University Of Michigan At Ann Arbor · UM1 · FY2014 · HG
Role of tumor cell cluster-induced signaling in breast cancer metastasis
$394,548Kevin Jon Cheung · Fred Hutchinson Cancer Center · R37 · FY2023 · CA
Development of Microbial-Based Therapies to Suppress Macropinocytosis in Kras-Driven Cancers
$394,548Edwin Manuel · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Targeting Vulnerabilities Exposed by Cancer Treatment-Induced Lineage Plasticity
$394,548Peter S Nelson · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Modeling to Minimize Detection Bias in Cancer Risk Prediction Studies
$394,532Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Diagnosis and longitudinal monitoring of metastatic prostate cancer through molecular MR imaging
$394,519Nicole Franziska Steinmetz · Case Western Reserve University · R01 · FY2017 · CA
PSMA Directed Imaging of Prostate Cancer Focus on Androgen Receptor Dynamics
$394,519Martin G Pomper · Johns Hopkins University · U01 · FY2016 · CA
Diagnosis and longitudinal monitoring of metastatic prostate cancer through molecular MR imaging
$394,519Nicole Franziska Steinmetz · Case Western Reserve University · R01 · FY2018 · CA
A diagnostic test for improved prostate cancer diagnosis in abnormal biopsies
$394,453Diha J Freije · Euclid Diagnostics, Llc · R43 · FY2010 · CA
Targeting Prostate Cancer Lineage Plasticity with BET Bromodomain Inhibition
$394,446Joshi James Alumkal · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
A First-in-Class FAP-activated Protoxin to disrupt the Tumor-Stroma Parasitic Cycle fueling lethal Prostate Cancer Progression
$394,398William Nathaniel Brennen · Johns Hopkins University · R01 · FY2024 · CA
IRE1/XBP1s signaling: a novel essential regulator for bone marrow microenvironmen
$394,328Hongjiao Ouyang · Texas A&M University Health Science Ctr · R01 · FY2017 · CA
Reagents for the Design of Targeted Multifunctional Nanomaterials
$394,268Lee Josephson · Massachusetts General Hospital · R01 · FY2010 · EB
Western New York Cancer Coalition (WNYC2) Center to Reduce Disparities
$394,263Willie Underwood · Roswell Park Cancer Institute Corp · U54 · FY2015 · CA
Project-1: Defining the mechanisms by which neurons promote breast cancer metastasis
$394,236Sohail F. Tavazoie · Rockefeller University · U54 · FY2022 · CA
Tumor and Circulating Markers as Links Between Obesity and Lethal Prostate Cance
$394,216Lorelei Mucci · Dana-Farber Cancer Inst · P50 · FY2014 · CA